CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1. Disease Prevention & Health Promotion (5 Questions)
Q1
Reference: Ch. 1 — Disease Prevention & Health Promotion —
Screening Recommendations
Question Stem:
A 55-year-old man with no significant medical history presents
for an annual exam. He has a 20 pack-year smoking history but
quit 10 years ago. Which preventive screening is most
appropriate?
,Options:
A. Chest X-ray annually
B. Low-dose CT scan for lung cancer
C. Sputum cytology every 3 years
D. Pulmonary function test screening
Correct Answer: B
Rationales:
• B (Correct): Annual low-dose CT scan is recommended for
adults aged 50–80 with ≥20 pack-year history who quit <15
years ago.
• A: Chest X-ray is not sensitive or specific for early lung
cancer detection.
• C: Sputum cytology has low sensitivity and is not
recommended for screening.
• D: Pulmonary function tests are used for symptomatic
evaluation, not screening.
Teaching Point:
Low-dose CT is preferred for lung cancer screening in high-risk
adults aged 50–80.
Citation: Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.), Ch. 1.
Q2
,Reference: Ch. 1 — Immunizations
Question Stem:
Which adult should receive both pneumococcal conjugate
(PCV15 or PCV20) and polysaccharide (PPSV23) vaccines?
Options:
A. A healthy 35-year-old
B. A 42-year-old with type 2 diabetes
C. A 65-year-old with chronic obstructive pulmonary disease
D. A 50-year-old with controlled hypertension
Correct Answer: C
Rationales:
• C (Correct): Adults ≥65 or those 19–64 with chronic lung
disease should receive pneumococcal vaccination.
• A, B, D: Routine pneumococcal vaccination is not indicated
for healthy or low-risk adults under 65.
Teaching Point:
Adults ≥65 or with chronic lung, heart, or immune disease need
pneumococcal vaccination.
Citation: Papadakis et al. (2025). CMDT 2026, Ch. 1.
Q3
Reference: Ch. 1 — Cancer Screening**
, Question Stem:
A 45-year-old woman with an average risk of colon cancer asks
when to begin screening. What is the correct response?
Options:
A. Begin at age 40
B. Begin at age 45
C. Begin at age 50
D. Begin at age 55
Correct Answer: B
Rationales:
• B (Correct): USPSTF and CMDT recommend starting colon
cancer screening at age 45 for average-risk adults.
• A, C, D: Earlier or later initiation may miss early detection
opportunities or lead to unnecessary testing.
Teaching Point:
Begin colorectal cancer screening at age 45 for average-risk
adults.
Citation: Papadakis et al. (2025). CMDT 2026, Ch. 1.
Q4
Reference: Ch. 1 — Lifestyle Modification
Question Stem:
A nurse counsels a 48-year-old patient with prehypertension
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1. Disease Prevention & Health Promotion (5 Questions)
Q1
Reference: Ch. 1 — Disease Prevention & Health Promotion —
Screening Recommendations
Question Stem:
A 55-year-old man with no significant medical history presents
for an annual exam. He has a 20 pack-year smoking history but
quit 10 years ago. Which preventive screening is most
appropriate?
,Options:
A. Chest X-ray annually
B. Low-dose CT scan for lung cancer
C. Sputum cytology every 3 years
D. Pulmonary function test screening
Correct Answer: B
Rationales:
• B (Correct): Annual low-dose CT scan is recommended for
adults aged 50–80 with ≥20 pack-year history who quit <15
years ago.
• A: Chest X-ray is not sensitive or specific for early lung
cancer detection.
• C: Sputum cytology has low sensitivity and is not
recommended for screening.
• D: Pulmonary function tests are used for symptomatic
evaluation, not screening.
Teaching Point:
Low-dose CT is preferred for lung cancer screening in high-risk
adults aged 50–80.
Citation: Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.), Ch. 1.
Q2
,Reference: Ch. 1 — Immunizations
Question Stem:
Which adult should receive both pneumococcal conjugate
(PCV15 or PCV20) and polysaccharide (PPSV23) vaccines?
Options:
A. A healthy 35-year-old
B. A 42-year-old with type 2 diabetes
C. A 65-year-old with chronic obstructive pulmonary disease
D. A 50-year-old with controlled hypertension
Correct Answer: C
Rationales:
• C (Correct): Adults ≥65 or those 19–64 with chronic lung
disease should receive pneumococcal vaccination.
• A, B, D: Routine pneumococcal vaccination is not indicated
for healthy or low-risk adults under 65.
Teaching Point:
Adults ≥65 or with chronic lung, heart, or immune disease need
pneumococcal vaccination.
Citation: Papadakis et al. (2025). CMDT 2026, Ch. 1.
Q3
Reference: Ch. 1 — Cancer Screening**
, Question Stem:
A 45-year-old woman with an average risk of colon cancer asks
when to begin screening. What is the correct response?
Options:
A. Begin at age 40
B. Begin at age 45
C. Begin at age 50
D. Begin at age 55
Correct Answer: B
Rationales:
• B (Correct): USPSTF and CMDT recommend starting colon
cancer screening at age 45 for average-risk adults.
• A, C, D: Earlier or later initiation may miss early detection
opportunities or lead to unnecessary testing.
Teaching Point:
Begin colorectal cancer screening at age 45 for average-risk
adults.
Citation: Papadakis et al. (2025). CMDT 2026, Ch. 1.
Q4
Reference: Ch. 1 — Lifestyle Modification
Question Stem:
A nurse counsels a 48-year-old patient with prehypertension
